Cargando…
Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report
Hemolytic anemia due to GPI deficiency can be severe and life threatening during fetal life. When parents decline invasive testing, ultrasound monitoring of fetuses at risk is feasible. Intrauterine transfusion can be effective for the treatment of severe fetal anemia due to GPI deficiency.
Autores principales: | Adama van Scheltema, Phebe N, Zhang, Ai, Ball, Lynne M, Steggerda, Sylke J, van Wijk, Richard, Fransen van de Putte, Dietje E, van Kamp, Inge L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614658/ https://www.ncbi.nlm.nih.gov/pubmed/26509025 http://dx.doi.org/10.1002/ccr3.358 |
Ejemplares similares
-
Hereditary nonspherocytic hemolytic anemia caused by glucose-6-phosphate isomerase (GPI) deficiency in a Chinese patient: a case report
por: Zu, Yumei, et al.
Publicado: (2022) -
Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication
por: Koene, Saskia, et al.
Publicado: (2020) -
Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures
por: Zwiers, C., et al.
Publicado: (2017) -
Immunization with the glycolytic enzyme glucose-6-phosphate isomerase (GPI) induces peripheral polyarthritis in genetically unaltered mice
por: Schubert, D, et al.
Publicado: (2004) -
Editorial: Pathophysiology of Rare Hemolytic Anemias
por: van Wijk, Richard, et al.
Publicado: (2020)